Legal Opinion
Janssen Pharmaceutica, N.V. v. Kappos
District Court, E.D. Virginia
Decided February 10, 2012No. 1:11cv969 (LMB/IDD)PublishedCited by 4 opinions
1Opinion of the Court
MEMORANDUM OPINION
LEONIE M. BRINKEMA, District Judge.
Plaintiff Janssen Pharmaceutica, N.V. (“Janssen”), a Belgian corporation that is the assignee of U.S. Patent No. 7,741,356 (“the patent” or “the '356 patent”), has sued the United States Patent and Trademark Office and its director, David J. Kappos, seeking a 98-day increase to the term of the '356 patent (“patent term” or “PTA”). Before the Court is defendants’ Motion to Dismiss, in which they argue that the Court does not have jurisdiction over this action, because when the complaint was filed on September 9, 2011, the applicable statute,…
2Cases cited14 opinions
- Kokkonen v. Guardian Life Insurance Co. of AmericaSupreme Court of the United States · 1994
- Exxon Mobil Corp. v. Allapattah Services, Inc.Supreme Court of the United States · 2005
- Brown v. General Services AdministrationSupreme Court of the United States · 1976
- Stone v. Immigration & Naturalization ServiceSupreme Court of the United States · 1995
- Block v. North Dakota Ex Rel. Board of University & School LandsSupreme Court of the United States · 1983
9 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Daiichi Sankyo Company, Limited v. KapposDistrict Court, District of Columbia · 2013
- Novartis Ag v. KapposDistrict Court, District of Columbia · 2012
- Janssen Pharmaceutica, N v. v. KapposDistrict Court, District of Columbia · 2013
- Guymon v. VidalDistrict Court, E.D. Virginia · 2025